Delivery Order SPE2DB25D3108-SPE2DB25FPDJQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Benicar 40 mg tablets (30-count packaging) under a firm fixed-price contract valued at $6,003.39. This non-set-aside award reflects a competitive procurement action for pharmaceutical products supporting federal medical supply needs. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,152.23 to AmerisourceBergen Drug Corp for the supply of Benicar 40 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,048.99 to AmerisourceBergen Drug Corp for Benicar 40 mg tablets (30-count units) under a firm fixed price contract type. The contract, which was competitively awarded with no set-aside designation, was finalized on August 12, 2025, with an ultimate completion date of August 13, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $74,538.88 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 30-count packages of 20 mg Benicar tablets. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 9, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was awarded under an existing DLA...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 31, 2025, calls for the supply of Benicar 5 mg tablets (30-count units) at a ceiling value of $1,085.10. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and is being funded by the Defense Logistics Agency (DLA), a defense agency responsible for supplying the military health system. The award carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,220.51 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 30 tablets of Benicar 20 mg to an address in Conshohocken, Pennsylvania, with performance required from June 26-27, 2023. As the prime contractor, Amerisourcebergen will fulfill the order without the use of major subcontractors. The Defense Logistics Agency functions include procuring pharmaceuticals and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $7,602 to Amerisourcebergen Drug Corporation to supply 30 packages of the prescription medication Benicar 20 mg tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The single day order period is from August 24 to August 25, 2023. The Defense Logistics Agency is a combat support agency under the United States Department of Defense responsible for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BENICAR 20 MG TABLET 30S. The contract has a total ceiling value of $2,578.84 and is a Firm Fixed Price contract. It was awarded on October 11, 2024 with an ultimate completion date of October 15, 2024. The contract does not have a set-aside designation. As a large pharmaceutical distributor, Amerisourcebergen leverages its...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.80 firm fixed-price delivery order is for the supply of BENICAR 20 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency awarded a $1,759 delivery order to Amerisourcebergen Drug Corporation for 4562160239 BENICAR 20 MG TABLET 30S. The firm fixed price order is being fulfilled under the Prime Vendor Pharmaceuticals contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 13-14, 2023. No set aside designation or subcontractors...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDJQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Benicar 20 mg tablets (30-count units) under a firm fixed price contract type. The contract, valued at $2,788.07, was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Logistics Agency's Medical Supply Chain operations, enabling the provision of essential pharmaceutical products to military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive track record of federal medical procurement through the DLA, supplying brand-name and generic medications across multiple therapeutic domains. The firm fixed pricing structure and rapid completion timeline reflect the agency's operational needs for pharmaceutical inventory replenishment within the broader federal healthcare procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/18/25 |